Yahanda AM - Search Results

1

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.

Yahanda AM, Alder KM, Fisher GA, Brophy NA, Halsey J, Hardy RI, Gosland MP, Lum BL, Sikic BI. Yahanda AM, et al. J Clin Oncol. 1992 Oct;10(10):1624-34. doi: 10.1200/JCO.1992.10.10.1624. J Clin Oncol. 1992. PMID: 1403040 Clinical Trial.

2

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.

Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI. Lum BL, et al. Among authors: yahanda am. J Clin Oncol. 1992 Oct;10(10):1635-42. doi: 10.1200/JCO.1992.10.10.1635. J Clin Oncol. 1992. PMID: 1403041 Clinical Trial.

3

Clinical reversal of multidrug resistance.

Sikic BI, Fisher GA, Lum BL, Brophy NA, Yahanda AM, Adler KM, Halsey J. Sikic BI, et al. Among authors: yahanda am. Cancer Treat Res. 1994;73:149-65. doi: 10.1007/978-1-4615-2632-2_8. Cancer Treat Res. 1994. PMID: 7710904 Review. No abstract available.

4

Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations.

Lum BL, Fisher GA, Brophy NA, Yahanda AM, Adler KM, Kaubisch S, Halsey J, Sikic BI. Lum BL, et al. Among authors: yahanda am. Cancer. 1993 Dec 1;72(11 Suppl):3502-14. doi: 10.1002/1097-0142(19931201)72:11+<3502::aid-cncr2820721618>3.0.co;2-n. Cancer. 1993. PMID: 7902206 Review.

5

Loss of DCC expression and glioma progression.

Reyes-Mugica M, Rieger-Christ K, Ohgaki H, Ekstrand BC, Helie M, Kleinman G, Yahanda A, Fearon ER, Kleihues P, Reale MA. Reyes-Mugica M, et al. Cancer Res. 1997 Feb 1;57(3):382-6. Cancer Res. 1997. PMID: 9012460

6

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.

Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER. Caca K, et al. Cell Growth Differ. 1999 Jun;10(6):369-76. Cell Growth Differ. 1999. PMID: 10392898

7

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.

Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, Caron S, Duboué B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, Eng C, et al. Marsh DJ, et al. Among authors: yahanda am. Hum Mol Genet. 1998 Mar;7(3):507-15. doi: 10.1093/hmg/7.3.507. Hum Mol Genet. 1998. PMID: 9467011

8

Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas.

Morrison RS, Yamaguchi F, Saya H, Bruner JM, Yahanda AM, Donehower LA, Berger M. Morrison RS, et al. Among authors: yahanda am. J Neurooncol. 1994;18(3):207-16. doi: 10.1007/BF01328955. J Neurooncol. 1994. PMID: 7964981 Review.

9

Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas.

Yahanda AM, Bruner JM, Donehower LA, Morrison RS. Yahanda AM, et al. Mol Cell Biol. 1995 Aug;15(8):4249-59. doi: 10.1128/MCB.15.8.4249. Mol Cell Biol. 1995. PMID: 7623819 Free PMC article.

10

Impact of morbid obesity on outcome of laparoscopic splenectomy.

Dominguez EP, Choi YU, Scott BG, Yahanda AM, Graviss EA, Sweeney JF. Dominguez EP, et al. Among authors: yahanda am. Surg Endosc. 2007 Mar;21(3):422-6. doi: 10.1007/s00464-006-9064-0. Epub 2006 Nov 14. Surg Endosc. 2007. PMID: 17103267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters